IFN-g

Molecular group: 
Cytokines and receptors
Molecule/Cell: 
IFN-g
Plasmodium strain: 
Plasmodium berghei ANKA
pRBC infection titer: 
10^6
Mouse genetic background (Con): 
CBA/Ca
Experimental treatment group (EG): 
anti-IFN-g
Lethal infection (Con): 
yes
Lethal infection (EG): 
yes
Pathology (Con): 
CM (87,5%)
Pathology (EG): 
CM (10-23,5%)
Parasitemia (EG vs Con): 
Similar
Additional phenotypes (EG vs Con): 
Prolonged survival (1-2 weeks); no neurological symptoms; no protection when administered just before onset of symptoms (day 7);↓ serum TNF-a; similar mononuclear cell infiltration in spleen and lymph nodes; no sequestration of macrophages, T cells or pRBC in the brain
Refs: 
Grau et al., 1989, Proc Natl Acad Sci U S A